Literature DB >> 9303204

The role of chemokines and accessory cells in the immunoregulation of cutaneous leishmaniasis.

H Moll1.   

Abstract

The course of infection with Leishmania parasites is determined by the type of the developing CD4+ T cell immune response. Macrophages and Langerhans cells/dendritic cells play a decisive role in the interaction between the parasites and the host's immune system because they serve as host cells, as accessory cells that present parasite antigen, deliver costimulatory signals and secrete cytokines modulating the T cell activity and as effector cells eliminating the microorganisms. Therefore, we put particular emphasis on characterizing the role of these cells in cutaneous leishmaniasis and the factors regulating their activities. Our results show that (1) expression of the chemokine monocyte chemoattractant protein 1 (MCP-1) is associated with macrophage infiltration into the lesion and stimulation of leishmanicidal activity, (2) Langerhans cells are required for the transport of Leishmania from the infected skin to the draining lymph node and initiation of the specific T cell immune response in the early phase of infection, (3) lymph node dendritic cells containing persistent parasites may be involved in the maintenance of specific immunity, (4) Langerhans cells are able to present L. major LPG to T cells and (5) treatment of mice with antigen-pulsed Langerhans cells induces protective immunity against cutaneous leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9303204

Source DB:  PubMed          Journal:  Behring Inst Mitt        ISSN: 0301-0457


  12 in total

Review 1.  Molecular machinations: chemokine signals in host-pathogen interactions.

Authors:  S W Chensue
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Chemokines in human periodontal disease tissues.

Authors:  E Gemmell; C L Carter; G J Seymour
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

3.  Leishmania major promastigotes inhibit dendritic cell motility in vitro.

Authors:  Heather Jebbari; Andrew J Stagg; Robert N Davidson; Stella C Knight
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major.

Authors:  B Vester; K Müller; W Solbach; T Laskay
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 5.  Role of chemokines in regulation of immunity against leishmaniasis.

Authors:  Steve Oghumu; Claudio M Lezama-Dávila; Angelica P Isaac-Márquez; Abhay R Satoskar
Journal:  Exp Parasitol       Date:  2010-03-03       Impact factor: 2.011

6.  Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages.

Authors:  Sean M Conrad; Dalit Strauss-Ayali; Ann E Field; Matthias Mack; David M Mosser
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

7.  Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major.

Authors:  Simone Antoniazi; Helen P Price; Pascale Kropf; Marina A Freudenberg; Chris Galanos; Deborah F Smith; Ingrid Müller
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  Response of the splenic dendritic cell population to malaria infection.

Authors:  Andrew L Leisewitz; Kirk A Rockett; Bonginkosi Gumede; Margaret Jones; Britta Urban; Dominic P Kwiatkowski
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

9.  Novel program of macrophage gene expression induced by phagocytosis of Leishmania chagasi.

Authors:  Nilda E Rodriguez; Haeok K Chang; Mary E Wilson
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  AgNP-PVP-meglumine antimoniate nanocomposite reduces Leishmania amazonensis infection in macrophages.

Authors:  Ana Patricia Cacua Gélvez; José Antonio Picanço Diniz Junior; Rebecca Thereza Silva Santa Brígida; Ana Paula Drummond Rodrigues
Journal:  BMC Microbiol       Date:  2021-07-12       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.